KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Current Deferred Revenue: 2009-2025

Historic Current Deferred Revenue for Thermo Fisher Scientific (TMO) over the last 16 years, with Sep 2025 value amounting to $2.9 billion.

  • Thermo Fisher Scientific's Current Deferred Revenue rose 7.10% to $2.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 billion, marking a year-over-year increase of 7.10%. This contributed to the annual value of $2.9 billion for FY2024, which is 6.06% up from last year.
  • According to the latest figures from Q3 2025, Thermo Fisher Scientific's Current Deferred Revenue is $2.9 billion, which was up 1.68% from $2.8 billion recorded in Q2 2025.
  • Thermo Fisher Scientific's Current Deferred Revenue's 5-year high stood at $2.9 billion during Q2 2022, with a 5-year trough of $1.4 billion in Q2 2021.
  • Moreover, its 3-year median value for Current Deferred Revenue was $2.7 billion (2024), whereas its average is $2.7 billion.
  • As far as peak fluctuations go, Thermo Fisher Scientific's Current Deferred Revenue spiked by 108.89% in 2021, and later declined by 7.28% in 2023.
  • Quarterly analysis of 5 years shows Thermo Fisher Scientific's Current Deferred Revenue stood at $2.7 billion in 2021, then decreased by 2.03% to $2.6 billion in 2022, then rose by 3.38% to $2.7 billion in 2023, then rose by 6.06% to $2.9 billion in 2024, then increased by 7.10% to $2.9 billion in 2025.
  • Its last three reported values are $2.9 billion in Q3 2025, $2.8 billion for Q2 2025, and $2.9 billion during Q1 2025.